FFCP PHASE1:Mm9::chr2:69252565..69252576,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=142 | |MCL_coexpression_id=142 | ||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr2:69252565..69252576,- | |||
|description=CAGE_peak_at_chr2:69252565..69252576,- | |description=CAGE_peak_at_chr2:69252565..69252576,- | ||
|id=chr2:69252565..69252576,- | |id=chr2:69252565..69252576,- | ||
|ontology_enrichment_celltype=CL:0000355!3.69e-15!9 | |ontology_enrichment_celltype=CL:0000355!3.69e-15!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.69e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!1.25e-43!3;DOID:4045!1.25e-43!3;DOID:0050686!2.64e-22!6 | |ontology_enrichment_disease=DOID:0060100!1.25e-43!3;DOID:4045!1.25e-43!3;DOID:0050686!2.64e-22!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.25e-43,3;DOID:4045,1.25e-43,3;DOID:0050686,2.64e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!3.69e-15!9;UBERON:0002036!3.69e-15!9;UBERON:0002385!3.69e-15!9;UBERON:0000486!3.69e-15!9;UBERON:0001015!3.69e-15!9;UBERON:0004290!3.69e-15!9;UBERON:0003082!3.69e-15!9;UBERON:0000383!1.00e-13!10;UBERON:0002329!1.50e-12!11;UBERON:0003077!1.50e-12!11;UBERON:0003059!1.50e-12!11;UBERON:0007282!1.50e-12!11;UBERON:0009618!1.50e-12!11;UBERON:0007285!1.50e-12!11;UBERON:0000914!2.23e-08!17 | |ontology_enrichment_uberon=UBERON:0001134!3.69e-15!9;UBERON:0002036!3.69e-15!9;UBERON:0002385!3.69e-15!9;UBERON:0000486!3.69e-15!9;UBERON:0001015!3.69e-15!9;UBERON:0004290!3.69e-15!9;UBERON:0003082!3.69e-15!9;UBERON:0000383!1.00e-13!10;UBERON:0002329!1.50e-12!11;UBERON:0003077!1.50e-12!11;UBERON:0003059!1.50e-12!11;UBERON:0007282!1.50e-12!11;UBERON:0009618!1.50e-12!11;UBERON:0007285!1.50e-12!11;UBERON:0000914!2.23e-08!17 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.69e-15,9;UBERON:0002036,3.69e-15,9;UBERON:0002385,3.69e-15,9;UBERON:0000486,3.69e-15,9;UBERON:0007503,3.69e-15,9;UBERON:0001015,3.69e-15,9;UBERON:0002329,3.69e-15,9;UBERON:0003082,3.69e-15,9;UBERON:0003059,3.69e-15,9;UBERON:0007282,3.69e-15,9;UBERON:0004290,3.69e-15,9;UBERON:0009618,3.69e-15,9;UBERON:0000383,1.00e-13,10;UBERON:0007524,1.50e-12,11;UBERON:0003077,1.50e-12,11;UBERON:0007285,1.50e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.7636447983192,17.9707129240474,5.75876118371178,23.5292595212406,58.7419117064263,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.7636447983192,17.9707129240474,5.75876118371178,23.5292595212406,58.7419117064263,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr2:69252565..69252576,- | |short_description=p@chr2:69252565..69252576,- | ||
}} | }} |
Latest revision as of 09:21, 5 August 2015
Short description: | p@chr2:69252565..69252576, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:69252565..69252576, - |
Coexpression cluster: | MCL_coexpression_mm9:142 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.69e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.69e-15 | 9 |
striated muscle tissue | 3.69e-15 | 9 |
muscle tissue | 3.69e-15 | 9 |
multilaminar epithelium | 3.69e-15 | 9 |
epithelial vesicle | 3.69e-15 | 9 |
musculature | 3.69e-15 | 9 |
somite | 3.69e-15 | 9 |
myotome | 3.69e-15 | 9 |
presomitic mesoderm | 3.69e-15 | 9 |
presumptive segmental plate | 3.69e-15 | 9 |
dermomyotome | 3.69e-15 | 9 |
trunk paraxial mesoderm | 3.69e-15 | 9 |
musculature of body | 1.00e-13 | 10 |
dense mesenchyme tissue | 1.50e-12 | 11 |
paraxial mesoderm | 1.50e-12 | 11 |
presumptive paraxial mesoderm | 1.50e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.25e-43 | 3 |
muscle cancer | 1.25e-43 | 3 |
organ system cancer | 2.64e-22 | 6 |